Video
GlaxoSmithKline ...Avandia,...Garnier says a buyback programme of that scale is unprecedented in the drug industry. But Reuters editor Mike Dolan says some of that anxiety appears to have eased ...
1m 59s |
a year ago
AOL
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Rosiglitazone
GlaxoSmithKline
A share
United States
Go to Feed to see what's new!
share
keep
 
 
...GlaxoSmithKline ...Bloomberg's Allan Dodds Frank in Gaithersburg, Maryland, about a Food and Drug Administration advisory panel's decision that Glaxo's diabetes pill Avandia should remain on the ...
a year ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Food and Drug Administration
GlaxoSmithKline
Pharmaceutical company
Gaithersburg, Maryland
Diabetes mellitus
Combined oral contraceptive pill
Go to Feed to see what's new!
share
keep
 
 
...Bloomberg's ...GlaxoSmithKline Plc's diabetes pill Avandia and the safety of Takeda Pharmaceutical Co.'s Actos. The panel decided that Avandia should remain on the market but be accompanied by new ...
a year ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Food and Drug Administration
GlaxoSmithKline
Cleveland Clinic
Pharmaceutical company
Steven Nissen
Rosiglitazone
Gaithersburg, Maryland
Go to Feed to see what's new!
share
keep
 
 
...Bloomberg's ...GlaxoSmithKline Plc's Avandia diabetes drug versus Takeda Pharmaceutical Co.'s Actos. Graham told a meeting of FDA advisers today that Avandia should be removed from the market ...
a year ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Food and Drug Administration
GlaxoSmithKline
Pharmaceutical company
United Kingdom
Pioglitazone
Gaithersburg, Maryland
David Graham (epidemiologist)
Go to Feed to see what's new!
share
keep
 
 
...GlaxoSmithKline ...Bloomberg's Francine Lacqua from London about first-quarter earnings, the company's drugs Avandia, Tykerb and Cervarix, and Glaxo's acquisition of Sirtris Pharmaceuticals Inc. ...
7 months ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
GlaxoSmithKline
United States
Chief executive officer
United Kingdom
Pharmaceutical company
Mergers and acquisitions
Go to Feed to see what's new!
share
keep
 
 
More Videos
 
Keep this video in the "Saved" list
Go to Feed to see what's new!
share
keep
 
 
 


 
Jean-Pierre Garnier, chief executive officer of GlaxoSmithKline Plc, talks with Bloomberg's Nina de Roy and Rishaad Salamat from Middlesex, England, about the safety of diabetes drug Avandia, the outlook for new products and second-quarter earnings reported today. A U.S. Food and Drug Administration committee meets on July 30 to review Avandia's safety after researchers said on May 21 that the diabetes pill may increase the chances of heart attacks by 43 percent. (Source: Bloomberg)
a year ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
GlaxoSmithKline
United Kingdom
Pharmaceutical company
Chief executive officer
Go to Feed to see what's new!
share
keep